On Monday, August 20th, the Food and Drug Administration announced the recall of the popular blood pressure medication containing valsartan was expanding.
The original recall for medication containing valsartan was live on July 13th, 2018. The recall was discovered after the active ingredient, valsartan, was found to have an impurity: N-nitrosodimethylamine (NDMA).
According to the FDA, “NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests.” NDMA has been known to cause cancer.
However, the FDA also states that “Not all valsartan products contain NDMA, so pharmacists may be able to provide a refill of valsartan medication not affected by the recall, or doctors may prescribe a different medication that treats the same condition." To get a full list of the affected medications, click here.
If you are not sure if your medication is affected by this recall, The FDA advises consumers to call 1-800-505-9291 or email email@example.com with any questions or concerns.
While the number of drugs affected is growing every day, it is important to reach out to your doctor if you are currently using any medication with this valsartan. Please consult your doctor.